Hemodynamics in the cardiac catheterization laboratory of the 21st century

Circulation

Volumn 125, Issue 17, 2012, Pages 2138-2150

  Nishimura, Rick A ^a   Carabello, Blase A ^b  

^a MAYO CLINIC   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Catheterization; Hemodynamics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISOPYRAMIDE; DOBUTAMINE;

ANGIOCARDIOGRAPHY; AORTA STENOSIS; BLOOD FLOW VELOCITY; CARDIOLOGIST; COMPUTER ANALYSIS; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART OUTPUT; HEART TRANSPLANTATION; HEART VALVE STENOSIS; HEMODYNAMIC PARAMETERS; HISTORY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MITRAL VALVE STENOSIS; OPEN HEART SURGERY; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PERICARDITIS; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RESTRICTIVE CARDIOMYOPATHY; REVIEW; TRANSLUMINAL VALVULOPLASTY; VALVULAR HEART DISEASE;

ALGORITHMS; CARDIAC OUTPUT; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; CORONARY ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DYSPNEA; EQUIPMENT DESIGN; EXERCISE TEST; FORECASTING; HEART CATHETERIZATION; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LABORATORIES; PERICARDITIS, CONSTRICTIVE; PRESSURE;

EID: 84860350162     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.060319     Document Type: Review

References (37)

1. Baum D. Cardiac catheterization history and current practice standards. In: Baim D, ed. Grossman's Cardiac Catheterization, Angiography, and Intervention. Philadelphia, Pa: Lippincott, Williams & Wilkins;2006: 3-13.
2. Nishimura RA, Tajik AJ. Quantitative hemodynamics by Doppler echocardiography: a noninvasive alternative to cardiac catheterization. Prog Cardiovasc Dis. 1994;36:309-342.
3. Carabello BA. Percutaneous therapy for valvular heart disease: a huge advance and a huge challenge to do it right. Circulation. 2010;121: 1798-1799.
4. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Halperin JL, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1-e121.
5. Carabello BA. Advances in the hemodynamic assessment of stenotic cardiac valves. J Am Coll Cardiol. 1987;10:912-919.
6. Wiggers C. Physiology in Health and Disease. Philadelphia, Pa: Lea and Febiger; 1945:733.
7. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve. Am Heart J. 1951;41:1-29.
8. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts, I. Am Heart J. 1951;41:1-29.
9. Hillis LD, Firth BG, Winniford MD. Analysis of factors affecting the variability of Fick versus indicator dilution measurements of cardiac output. Am J Cardiol. 1985;56:764-768.
10. Assey ME, Zile MR, Usher BW, Karavan MP, Carabello BA. Effect of catheter positioning on the variability of measured gradient in aortic stenosis. Cathet Cardiovasc Diagn. 1993;30:287-292.
11. Carabello BA. What exactly is 2+ to 3+ mitral regurgitation? J Am Coll Cardiol. 1992;19:339-340.
12. Folland ED, Parisi AF, Carbone C. Is peripheral arterial pressure a satisfactory substitute for ascending aortic pressure when measuring aortic valve gradients? J Am Coll Cardiol. 1984;4:1207-1212.
13. Carabello BA. What is new in the 2006 Acc/Aha guidelines on valvular heart disease? Curr Cardiol Rep. 2008;10:85-90.
14. Carabello BA, Barry WH, Grossman W. Changes in arterial pressure during left heart pullback in patients with aortic stenosis: a sign of severe aortic stenosis. Am J Cardiol. 1979;44:424-427.
15. Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C, Pop C, Ohlmann P, Lelguen C, Dehant P, Tribouilloy C, Gueret P. Lowgradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108:319-324.
16. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 2002;106:809-813.
17. Dumesnil JG, Pibarot P, Carabello B. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J. 2010;31: 281-289.
18. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007; 115:2856-2864.
19. Nishimura RA, Rihal CS, Tajik AJ, Holmes DR Jr. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol. 1994;24:152-158.
20. Klarich KW, Rihal CS, Nishimura RA. Variability between methods of calculating mitral valve area: simultaneous Doppler echocardiographic and cardiac catheterization studies conducted before and after percutaneous mitral valvuloplasty. J Am Soc Echocardiogr. 1996;9:684-690.
21. Alpert JS. The lessons of history as reflected in the pulmonary capillary wedge pressure. J Am Coll Cardiol. 1989;13:830-831.
22. Lange RA, Moore DM Jr, Cigarroa RG, Hillis LD. Use of pulmonary capillary wedge pressure to assess severity of mitral stenosis: is true left atrial pressure needed in this condition? J Am Coll Cardiol. 1989;13: 825-831.
23. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol. 2008;52:319-326.
24. Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, Seward JB. Unlocking the mysteries of diastolic function: deciphering the Rosetta stone 10 years later. J Am Coll Cardiol. 2008;51:679-689.
25. Park SJ, Nishimura RA, Borlaug BA, Sorajja P, Oh JK. The effect of loading alterations on left ventricular torsion: a simultaneous catheterization and two-dimensional speckle tracking echocardiographic study. Eur J Echocardiogr. 2010;11:770-777.
26. Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3:588-595.
27. Mahapatra S, Nishimura RA, Sorajja P, Cha S, McGoon MD. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol. 2006;47:799-803.
28. Nishimura RA. Constrictive pericarditis in the modern era: a diagnostic dilemma. Heart. 2001;86:619-623.
29. Talreja DR, Nishimura RA, Oh JK, Holmes DR. Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory. J Am Coll Cardiol. 2008;51:315-319.
30. Jaber WA, Sorajja P, Borlaug BA, Nishimura RA. Differentiation of tricuspid regurgitation from constrictive pericarditis: novel criteria for diagnosis in the cardiac catheterisation laboratory. Heart. 2009;95: 1449-1454.
31. Nishimura RA, Holmes DR Jr. Clinical practice: hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004;350:1320-1327.
32. Wigle ED. Novel insights into the clinical manifestations and treatment of hypertrophic cardiomyopathy. Curr Opin Cardiol. 1995;10:299-305.
33. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis. 1985; 28:1-83.
34. Wigle ED, Rakowski H. Evidence for true obstruction to left ventricular outflow in obstructive hypertrophic cardiomyopathy (muscular or hypertrophic subaortic stenosis). Z Kardiol. 1987;76(suppl 3):61-68.
35. Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR Jr. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008; 118:131-139.
36. Nishimura RA, Ommen SR. Hypertrophic cardiomyopathy: the search for obstruction. Circulation. 2006;114:2200-2202.
37. Elesber A, Nishimura RA, Rihal CS, Ommen SR, Schaff HV, Holmes DR Jr. Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2008;101:516-520.